Groups

BNP
[pg/ml]

NT-proBNP
[pg/ml]

ANP
[pg/ml]

NT-proANP
[nmol/l]

AD-EDMD

42 (18-54) *,#

85 (17-195) *

273 (1.3-366)

0.50 (0.28-0.58) ##

X-EDMD

24 (6-105) #

53 (14-192)

366 (0.9-391)

0.54 (0.37-0.60) ##

X-EDMD carriers

22 (9-62)

87 (33-400)

8.1 (0.9-8.1)

0.34 (0.29-0.65)

Dystrophinopathies

163 (50-337) ***

103 (9-457) *

344 (286-362) ***

2.5 (1.6-2.6) ***

Healthy controls

15 (9-20)

29 (15-49)

4.9 (2.3-5.6)

0.38 (0.32-0.42)

Medians and interquartile ranges are presented
* p<0.05, ** p<0.005, *** p<0.0005 for the patient groups vs. healthy controls
# p<0.05, ## p<0.005; AD-EDMD or X-EDMD patients vs. disease controls

Table 2: Natriuretic peptide concentrations in EDMD patients and controls